Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

PBI-4050 demonstrates promising antifibrotic properties in vivo

June 11, 2013

La Jolla Pharmaceutical submits IND to the FDA for LJPC-501

June 5, 2013

Otsuka files application in Japan for tolvaptan in autosomal dominant polycystic kidney disease

June 3, 2013

Targacept reports commencement of phase IIb TC-5214 study

May 31, 2013

Data show GCS-100 may improve renal function

May 27, 2013

Netherlands first to approve Vesomni

May 23, 2013

Dosing completed in phase I TTI-1612 study

May 17, 2013

Mirabegron/solifenacin as an effective therapeutic option for overactive bladder

May 16, 2013

Fedovapagon effectively reduces nocturia in men with BPH

May 15, 2013

Relypsa completes enrollment in pivotal phase III trial of patiromer

May 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...